Results 201 to 210 of about 16,806 (319)
Immunoglobulin Components of "Gamma" Globulin in Human Serum [PDF]
Virginia Trevorrow +2 more
openalex +1 more source
Abstract Aims Prednisone is a widely used glucocorticoid in the treatment of lupus, although its dosing is often determined empirically. Prednisolone, the active metabolite of prednisone, is found in its free form in the serum. The goal of this study was to develop a population pharmacokinetic model in patients with systemic lupus erythematosus (SLE ...
Naïm Bouazza +26 more
wiley +1 more source
Impact of hemoparasite load on hematological, biochemical, and immunological parameters in ISA Brown laying hens in southern Togo. [PDF]
Vinakpon G +5 more
europepmc +1 more source
Prediction of Lung Cancer Metastasis Using Machine Learning Models Based on Clinical Laboratory Data
ABSTRACT Background Lymph node (N) or/and distant metastasis in lung cancer indicates poorer prognosis. While laboratory tests and computed tomography (CT) scans reflect tumor growth and metabolic activity, they usually require combination with other diagnostic methods to effectively assess metastasis, resulting in limited clinical use of these results.
Chao Du +6 more
wiley +1 more source
Vaccination of Infants with Living Attenuated Measles Vaccine (Edmonston Strain) with and without Gamma-globulin [PDF]
P. F. Benson +6 more
openalex +1 more source
Autoimmune Type 1 Diabetes in the Era of Disease‐Modifying Immune Therapy
While disease‐modifying therapies (DMTs) have been used to treat autoimmune diseases for decades, until recently, DMTs had not been used to treat autoimmune type 1 diabetes (T1D). The approval of the first DMT for use in individuals with preclinical T1D, teplizumab, has ushered in a new era in which healthcare providers can slow the T1D disease course.
Aaron W. Michels +3 more
wiley +1 more source
Hypergammaglobulinemia in Hidradenitis Suppurativa Patients: A New Emerging Association. [PDF]
Martora F +4 more
europepmc +1 more source
Effect of Gamma Globulin on Measles [PDF]
Harold M. Sterling +2 more
openaire +3 more sources
Are We Ready With Prevention for Type 1 Diabetes?
ABSTRACT Definitive prevention for type 1 diabetes (T1D) is not yet available, but we are now entering a new era where disease‐modifying therapies are becoming available in T1D to halt disease progression. In this review, we present up‐to‐date knowledge related to the prevention of T1D in youth, involving disease‐modifying therapies at different T1D ...
Evelina Maines +3 more
wiley +1 more source

